Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience.

Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience.

AIM: A pilot study was undertaken to determine the accuracy of computed tomography (CT) staging in identifying patients with high-risk colon cancers who would be considered as candidates for a neoadjuvant therapy trial (FOxTROT) and those at low risk (T1/T2) who would be excluded. METHOD: Participa...

Full description

Bibliographic Details
Main Authors:	Dighe, S, Swift, I, Magill, L, Handley, K, Gray, R, Quirke, P, Morton, D, Seymour, M, Warren, B, Brown, G
Format:	Journal article
Language:	English
Published:	2012

Similar Items

FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report
by: Morton, D, et al.
Published: (2011)

FOxTROT: Randomized phase II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer
by: Gray, R, et al.
Published: (2010)

Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
by: Morton, U, et al.
Published: (2012)

Histopathological Downstaging of Colon Cancer Following Six Weeks of Pre-operative Chemotherapy: Early Results of the NCRI FOxTROT Trial
by: West, N, et al.
Published: (2012)

Neoadjuvant Chemotherapy for Colon Cancer
by: Marc T. Roth, et al.
Published: (2020-09-01)

Neoadjuvant chemotherapy for colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01)

KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
by: West, N, et al.
Published: (2012)

The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency
by: Wu Yunlong, et al.
Published: (2023-02-01)

Assessment of response of neoadjuvant chemotherapy in carcinoma breast patients by high-frequency ultrasound
by: Sajika Dighe, et al.
Published: (2022-01-01)

Tumor regression after neoadjuvant chemotherapy in locally advanced colon cancer
by: A. O. Rasulov, et al.
Published: (2015-10-01)

Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study
by: Mehmet Unsal, et al.
Published: (2023-12-01)

Radiological Assessment and Outcome of Local Disease Progression after Neoadjuvant Chemotherapy in Children and Adolescents with Localized Osteosarcoma
by: Adriana Fonseca, et al.
Published: (2020-12-01)

Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study
by: Haijun Tang, et al.
Published: (2022-01-01)

Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis
by: Wei Zeng, et al.
Published: (2022-10-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
by: Khudair J. Sabeeh Al-Rawaq
Published: (2012-04-01)

Mismatch Repair Testing in Colorectal Cancer - Is Less More?
by: Hutchins, G, et al.
Published: (2012)

Ultrasound Accuracy in Detection of Metastatic Axillary Lymph Nodes in Breast Cancer after Neoadjuvant Chemotherapy
by: Majid Akrami, et al.
Published: (2023-01-01)

The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: A systematic review and meta-analysis
by: Zongyu Liang, et al.
Published: (2022-10-01)

Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study
by: Antoni Llueca, et al.
Published: (2023-08-01)

Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre studyResearch in context
by: Caixia Sun, et al.
Published: (2019-08-01)

Accuracy of Breast Ultrasonography and Mammography in Comparison with Postoperative Histopathology in Breast Cancer Patients after Neoadjuvant Chemotherapy
by: Gilda Schmidt, et al.
Published: (2023-08-01)

Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response
by: P. V. Krivorotko, et al.
Published: (2022-12-01)

The prognostic value of radiological and pathological lymph node status in patients with cervical cancer who underwent neoadjuvant chemotherapy and followed hysterectomy
by: Jianghua Lou, et al.
Published: (2024-01-01)

Colon cancer with extensive invasion of the abdominal wall treated with neoadjuvant chemotherapy and a free anterolateral thigh flap
by: Tsukasa Aritake, et al.
Published: (2022-08-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
by: Daoan Cheng, et al.
Published: (2023-02-01)

Effects of neoadjuvant chemotherapy for patients with obstructive colon cancer: A multicenter propensity score‐matched analysis (YCOG2101)
by: Kazuya Nakagawa, et al.
Published: (2024-03-01)

Response Prediction after Neoadjuvant Chemotherapy for Colon Cancer Using CT Tumor Regression Grade: A Preliminary Study
by: Hwan Ju Je, et al.
Published: (2023-09-01)

Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy
by: Wen-juan Ma, et al.
Published: (2022-05-01)

Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study
by: Meijuan Xiang, et al.
Published: (2022-10-01)

Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer
by: Takehiro Okabayashi, et al.
Published: (2022-11-01)

PIK3CA Mutation is Strongly Associated with K-ras 12/13 Mutation in Stage II/III Colorectal Cancer
by: Southward, K, et al.
Published: (2012)

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
by: Gray, R, et al.
Published: (2011)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
by: Ami Patel, et al.
Published: (2021-02-01)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
by: Federica Papaccio, et al.
Published: (2020-12-01)

Recent advance in neoadjuvant chemotherapy for rectal cancer
by: GUO Yang, GUO Tian′an, XU Ye
Published: (2022-07-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
by: Valentina Iotti, et al.
Published: (2021-03-01)